A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Cholestyramine
Clevidipine
Clevidipine may increase the hyperkalemic activities of Potassium bicarbonate.
Cholestyramine
Nebivolol
Nebivolol may increase the hyperkalemic activities of Potassium bicarbonate.
Cholestyramine
Celiprolol
Celiprolol may increase the hyperkalemic activities of Potassium bicarbonate.
Cholestyramine
Fluspirilene
Fluspirilene may increase the hyperkalemic activities of Potassium bicarbonate.
Cholestyramine
Flunarizine
Flunarizine may increase the hyperkalemic activities of Potassium bicarbonate.
Cholestyramine
Cyclandelate
Cyclandelate may increase the hyperkalemic activities of Potassium bicarbonate.
Cholestyramine
Prenylamine
Prenylamine may increase the hyperkalemic activities of Potassium bicarbonate.
Cholestyramine
Penicillin G Acyl-Serine
Penicillin G Acyl-Serine may increase the hyperkalemic activities of Potassium bicarbonate.
Cholestyramine
Candesartan
Potassium bicarbonate may increase the hyperkalemic activities of Candesartan.
Cholestyramine
Azilsartan medoxomil
Potassium bicarbonate may increase the hyperkalemic activities of Azilsartan medoxomil.
Cholestyramine
Saralasin
Potassium bicarbonate may increase the hyperkalemic activities of Saralasin.
Cholestyramine
Bromotheophylline
Bromotheophylline may increase the excretion rate of Potassium bicarbonate which could result in a lower serum level and potentially a reduction in efficacy.
Cholestyramine
Epitizide
Epitizide may increase the excretion rate of Potassium bicarbonate which could result in a lower serum level and potentially a reduction in efficacy.
Cholestyramine
Xipamide
Xipamide may increase the excretion rate of Potassium bicarbonate which could result in a lower serum level and potentially a reduction in efficacy.
Cholestyramine
Muzolimine
Muzolimine may increase the excretion rate of Potassium bicarbonate which could result in a lower serum level and potentially a reduction in efficacy.
Cholestyramine
Clopamide
Clopamide may increase the excretion rate of Potassium bicarbonate which could result in a lower serum level and potentially a reduction in efficacy.
Cholestyramine
Fenquizone
Fenquizone may increase the excretion rate of Potassium bicarbonate which could result in a lower serum level and potentially a reduction in efficacy.
Cholestyramine
Clofenamide
Clofenamide may increase the excretion rate of Potassium bicarbonate which could result in a lower serum level and potentially a reduction in efficacy.
Cholestyramine
Clorexolone
Clorexolone may increase the excretion rate of Potassium bicarbonate which could result in a lower serum level and potentially a reduction in efficacy.
Cholestyramine
Cyclopenthiazide
Cyclopenthiazide may increase the excretion rate of Potassium bicarbonate which could result in a lower serum level and potentially a reduction in efficacy.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3